Revitalist and Wake Network, Inc.
Drug discovery and development company Mindset Pharma has filed for national patents protecting “Family 1” – second-generation psilocybin analogues – in 16 different countries, including South...
The 2022 International Forum on Consciousness returns with its 2022 topic “As Above, So Below”, and will feature a diverse group of thought leaders to explore...
World renowned auction house Christie’s partnered with the Multidisciplinary Association for Psychedelic Studies (MAPS) and leading artists to raise funds that will be donated to MAPS to support the...
The US food and Drugs Administration (FDA) has given approval for MYCO-001 in a recent Investigational New Drug (IND) application, which will now be used in...
Dimensions has launched its new international plant medicine retreat series in Jamaica.
Christie’s is presenting its Non-Fungible Token (NFT) auction – ‘Cartography of the Mind’ – to raise funds for the Multidisciplinary Association for Psychedelic Studies (MAPS).
Nirvana Life Sciences has announced it is making progress with its Health Canada Dealer’s licence application and its facility development.
The licence will enable research that will give a deeper understanding of psychedelic mushrooms and their interaction with the human body.
Psyched Wellness presented its proprietary extract of the Amanita Muscaria mushroom, AME-1, to Health Canada representatives to discuss the evidence required in support of a Class...
